
Troy Chambers
Examiner (ID: 10649)
| Most Active Art Unit | 3641 |
| Art Unit(s) | 3658, 3641 |
| Total Applications | 1156 |
| Issued Applications | 718 |
| Pending Applications | 122 |
| Abandoned Applications | 316 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 19716201
[patent_doc_number] => 12201717
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-01-21
[patent_title] => Compositions and methods for supporting skin barrier homeostasis
[patent_app_type] => utility
[patent_app_number] => 18/497102
[patent_app_country] => US
[patent_app_date] => 2023-10-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6847
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 175
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18497102
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/497102 | Compositions and methods for supporting skin barrier homeostasis | Oct 29, 2023 | Issued |
Array
(
[id] => 19722658
[patent_doc_number] => 20250025409
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-01-23
[patent_title] => READY-TO-INFUSE PHENYLEPHRINE COMPOSITIONS
[patent_app_type] => utility
[patent_app_number] => 18/243271
[patent_app_country] => US
[patent_app_date] => 2023-09-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11214
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18243271
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/243271 | READY-TO-INFUSE PHENYLEPHRINE COMPOSITIONS | Sep 6, 2023 | Pending |
Array
(
[id] => 18522828
[patent_doc_number] => 20230233477
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-07-27
[patent_title] => Bi2O3 NANOPARTICLES PREPARED BY THE TOP-DOWN ULTRASONICATION ROUTE AS A BROAD-SPECTRUM ANTIMICROBIAL TO OVERCOME DRUG RESISTANCE IN ANTIBIOTICS
[patent_app_type] => utility
[patent_app_number] => 18/102272
[patent_app_country] => US
[patent_app_date] => 2023-01-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6861
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18102272
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/102272 | Bi2O3 NANOPARTICLES PREPARED BY THE TOP-DOWN ULTRASONICATION ROUTE AS A BROAD-SPECTRUM ANTIMICROBIAL TO OVERCOME DRUG RESISTANCE IN ANTIBIOTICS | Jan 26, 2023 | Abandoned |
Array
(
[id] => 19279793
[patent_doc_number] => 20240216265
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-07-04
[patent_title] => LIPOSOMAL VEGAN PROBIOTIC SKIN TREATMENT
[patent_app_type] => utility
[patent_app_number] => 18/148583
[patent_app_country] => US
[patent_app_date] => 2022-12-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4098
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -4
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18148583
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/148583 | LIPOSOMAL VEGAN PROBIOTIC SKIN TREATMENT | Dec 29, 2022 | Abandoned |
Array
(
[id] => 18404418
[patent_doc_number] => 20230165768
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-01
[patent_title] => SKIN CARE COMPOSITION
[patent_app_type] => utility
[patent_app_number] => 18/070575
[patent_app_country] => US
[patent_app_date] => 2022-11-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12002
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18070575
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/070575 | Skin care composition | Nov 28, 2022 | Issued |
Array
(
[id] => 18581485
[patent_doc_number] => 20230263737
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-24
[patent_title] => SOFT GEL CAPSULE PREPARATIONS
[patent_app_type] => utility
[patent_app_number] => 18/055880
[patent_app_country] => US
[patent_app_date] => 2022-11-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14575
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 176
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18055880
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/055880 | SOFT GEL CAPSULE PREPARATIONS | Nov 15, 2022 | Abandoned |
Array
(
[id] => 19372965
[patent_doc_number] => 12064504
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-08-20
[patent_title] => Cosmetic compositions comprising high amounts of trifluoromethylhenyl valylglycine
[patent_app_type] => utility
[patent_app_number] => 18/050526
[patent_app_country] => US
[patent_app_date] => 2022-10-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17023
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 214
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18050526
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/050526 | Cosmetic compositions comprising high amounts of trifluoromethylhenyl valylglycine | Oct 27, 2022 | Issued |
Array
(
[id] => 18344624
[patent_doc_number] => 20230132734
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-04
[patent_title] => HAIR TREATMENT COMPOSITION
[patent_app_type] => utility
[patent_app_number] => 18/050096
[patent_app_country] => US
[patent_app_date] => 2022-10-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19300
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 87
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18050096
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/050096 | Hair treatment composition | Oct 26, 2022 | Issued |
Array
(
[id] => 19737186
[patent_doc_number] => 12213993
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-02-04
[patent_title] => Coated medicinal clay compositions, pharmaceutical compositions, and delivery of cation sources and methods of use thereof
[patent_app_type] => utility
[patent_app_number] => 18/049095
[patent_app_country] => US
[patent_app_date] => 2022-10-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 23
[patent_no_of_words] => 21264
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 218
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18049095
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/049095 | Coated medicinal clay compositions, pharmaceutical compositions, and delivery of cation sources and methods of use thereof | Oct 23, 2022 | Issued |
Array
(
[id] => 18076008
[patent_doc_number] => 20220401620
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-22
[patent_title] => COMPOSITION OF SUBSTANTIALLY SPHERICAL GRANULE FOR BONE REGENERATION
[patent_app_type] => utility
[patent_app_number] => 17/845168
[patent_app_country] => US
[patent_app_date] => 2022-06-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7632
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17845168
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/845168 | Composition of substantially spherical granule for bone regeneration | Jun 20, 2022 | Issued |
Array
(
[id] => 18018812
[patent_doc_number] => 20220370311
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-11-24
[patent_title] => APPLICATION OF HYDROGEN ION WATER AND A MASK CONTAINING HYDROGEN ION WATER
[patent_app_type] => utility
[patent_app_number] => 17/751815
[patent_app_country] => US
[patent_app_date] => 2022-05-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2837
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17751815
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/751815 | APPLICATION OF HYDROGEN ION WATER AND A MASK CONTAINING HYDROGEN ION WATER | May 23, 2022 | Abandoned |
Array
(
[id] => 17685660
[patent_doc_number] => 20220192952
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-23
[patent_title] => Chlorhexidine-Cyclamate Complexes and Oral Care Compositions Comprising the Same
[patent_app_type] => utility
[patent_app_number] => 17/695100
[patent_app_country] => US
[patent_app_date] => 2022-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3836
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17695100
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/695100 | Chlorhexidine-cyclamate complexes and oral care compositions comprising the same | Mar 14, 2022 | Issued |
Array
(
[id] => 19808328
[patent_doc_number] => 12239687
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-03-04
[patent_title] => Sustained release formulations using non-aqueous membrane emulsification
[patent_app_type] => utility
[patent_app_number] => 17/535267
[patent_app_country] => US
[patent_app_date] => 2021-11-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 38
[patent_no_of_words] => 13406
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 164
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17535267
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/535267 | Sustained release formulations using non-aqueous membrane emulsification | Nov 23, 2021 | Issued |
Array
(
[id] => 19870350
[patent_doc_number] => 12263188
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-04-01
[patent_title] => Methods and compositions for treating stroke
[patent_app_type] => utility
[patent_app_number] => 17/187437
[patent_app_country] => US
[patent_app_date] => 2021-02-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 7
[patent_no_of_words] => 10653
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 70
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17187437
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/187437 | Methods and compositions for treating stroke | Feb 25, 2021 | Issued |
Array
(
[id] => 16760947
[patent_doc_number] => 20210106528
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-04-15
[patent_title] => COMBINED PHARMACEUTICAL FORMULATION COMPRISING GEMCITABINE-CONTAINING LIPOSOME COMPOSITION AND IMMUNE CHECKPOINT INHIBITOR
[patent_app_type] => utility
[patent_app_number] => 17/125291
[patent_app_country] => US
[patent_app_date] => 2020-12-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15974
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 68
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17125291
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/125291 | Combined pharmaceutical formulation comprising gemcitabine-containing liposome composition and immune checkpoint inhibitor | Dec 16, 2020 | Issued |
Array
(
[id] => 18091203
[patent_doc_number] => 20220409544
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-29
[patent_title] => STABLE PARENTERAL FORMULATIONS OF DULOXETINE
[patent_app_type] => utility
[patent_app_number] => 17/778906
[patent_app_country] => US
[patent_app_date] => 2020-11-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8745
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17778906
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/778906 | STABLE PARENTERAL FORMULATIONS OF DULOXETINE | Nov 29, 2020 | Abandoned |
Array
(
[id] => 17342180
[patent_doc_number] => 20220008511
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-13
[patent_title] => TUMOR TREATMENT USING CYTOKINES AND CANCER DRUGS
[patent_app_type] => utility
[patent_app_number] => 16/926767
[patent_app_country] => US
[patent_app_date] => 2020-07-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6511
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16926767
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/926767 | TUMOR TREATMENT USING CYTOKINES AND CANCER DRUGS | Jul 11, 2020 | Abandoned |
Array
(
[id] => 17685704
[patent_doc_number] => 20220192996
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-23
[patent_title] => CORE-SHELL STRUCTURE, PREPARATION, MEDICINE FOR EXTERNAL APPLICATION, TAPE AGENT AND COSMETIC PRODUCT
[patent_app_type] => utility
[patent_app_number] => 17/599251
[patent_app_country] => US
[patent_app_date] => 2020-03-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15448
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 101
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17599251
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/599251 | CORE-SHELL STRUCTURE, PREPARATION, MEDICINE FOR EXTERNAL APPLICATION, TAPE AGENT AND COSMETIC PRODUCT | Mar 26, 2020 | Abandoned |
Array
(
[id] => 17609721
[patent_doc_number] => 20220152000
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-19
[patent_title] => PROLONGED RELEASE FORMULATION COMPRISING TACROLIMUS
[patent_app_type] => utility
[patent_app_number] => 17/441033
[patent_app_country] => US
[patent_app_date] => 2020-03-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4127
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 58
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17441033
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/441033 | PROLONGED RELEASE FORMULATION COMPRISING TACROLIMUS | Mar 18, 2020 | Pending |
Array
(
[id] => 19808254
[patent_doc_number] => 12239613
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-03-04
[patent_title] => Preparation method for carotenoid preparation having high bioavailability and high stability
[patent_app_type] => utility
[patent_app_number] => 17/440198
[patent_app_country] => US
[patent_app_date] => 2020-03-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5722
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 263
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17440198
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/440198 | Preparation method for carotenoid preparation having high bioavailability and high stability | Mar 9, 2020 | Issued |